INTRODUCTION
Pakistan is a developing country of 180 million people with low health and educational standards. According to the Human Development Index of the United Nations, it is ranked 146th out of 187 countries. 1 Pakistan carries one of the world's highest burden of chronic hepatitis viruses (both Hepatitis B virus---HBV and Hepatitis C Virus---HCV)and mortality due to liver cirrhosis and heap to cellular carcinoma. 2 In Pakistan, studies carried out on different segments of population have shown variable degree of prevalence in different risk groups. According to an estimate, there are about 9 million hepatitis B and over 14 million hepatitis C carriers all over the country.The prevalence of Hepatitis B Surface Antigen (HBs Ag) and antibodies to hepatitis C virus (anti-HCV) in young healthy Pakistani adults in recent studies carried out in different cross sections of population has ranged from 2.56 -3.53% and 2.3 -5.3% respectively 3,4,5 with segments of much higher prevalence as noted by Umer et al. 6 However, most of these studies are based on healthy young individuals, usually as a part of pre-employment screening or blood donation which may not be a true cross-section of the whole community.This was highlighted in a review by Bosan et al 7 where the lack of adequate community-based epidemiological work in Pakistan was noted.
To eradicate and control Hepatitis B and C virus from population as desired by WHO, it is important to know the as actual burden of illness as possible and to determine where we actually stand as far as the prevention of the disease is concerned after 24 years of HCV discovery and the availability of effective HBV vaccination. This is important as some developing countries have achieved much on the prevention front of Hepatitis B crease the diagnosis and treatment 5 fold. 9 So we planned a community-based cross-sectional study at Ibn-e-Siena Hospital and Research Centre to examine the prevalence of HBsAg and Anti-HCV in Southern Punjab population.
Study design
It was designed to be Cross-sectional, Observational study.
Place and Duration of Study
The study was carried out in Ibn-e-Sina Hospital and Research Centre from March 2010 to February 2014.
METHODOLOGY
A total of 26800 people from general population were included in the present study. Free vaccinationcamps were established in rural and urban union councils with the help of local politicians, in Schools, Madrassahs and Industrial units and a permanent camp was established in Ibn-e-Sina Hospital. People of all age groups andeither sex were vaccinated. Brief clinical history was recorded. For screening of HBsAg the architect HBsAg assay which is a chemi-luminescent micro practice leimmuno assays (CMIA) for quantitative determination ofhepatitis B surface antigen (HBsAg) was used. This was provided by Abbott diagnostics. For HCV, ACON laboratories kit was used. The HCV one step test device (Serum/Plasma) is a rapid chromatographicimmunoassay for the qualitative detection of antibody toHepatitis C virus in serum or plasma. The directions ofthe manufacturers were strictly followed.
RESULTS
A total of 26800 individuals were screened, (mean: 36.47 ± 13.81). 2090 (7.8%) tested positive for Anti-HCV. Among these 68.6 %( n=1433) were males while 31.4% (n=657) were females. 616 (2.3%) tested positive for HBsAg of which 401 (65.2%) were male and 215 (34.8%) were female. 75 subjects (0.28%) were positive for both HBsAg and Anti-HCV.
The age range of the patients with seropositivity is shown in ( 
DISCUSSION
Ours study results confirm that the menace of hepatitis continues to haunt our population. In our study, prevalence of Anti-HCV was higher than HBsAg as found in other local studies.
A study by Mirza et al 23 of 1821 healthy recruits from Southern Punjab in 2005-2006 showed 5.9% HBsAg and 2.5% Anti-HCV seropositivity However this study only young recruits with predominance of seropositivity from MuzaffarGarh. We think this study did not reflect the load of disease in general population of Southern Punjab.
As far as prevalence of HbsAg and Anti-HCV in general population is concerned, our study found the prevalence of HBsAg (2.3%) similar to that observed by another large study conducted by Khokhar et a----------2.5% 5 and the National Survey conducted by PMRC ---2.5%. 4 This reflects that we have not moved much in the prevention of HBV transmission. This is worrisome as HBV is totally preventable and certain Far Eastern Countries have achieved much in this regard. 8 The Prevalence of Anti-HCV (7.8%) observed in our study was higher than observed in the National Survey ----5% 4 and other studies/meta-analysis with large population. 3, 5, 6, 10, 22 But this difference can be explained by the fact thatfirst, ours area of study included the districts which have been reported to have the highest prevalence of Anti-HCV in the country>. 5 However, PMRC survey of the Multan District which included 1019 persons showed 7.4% prevalence which is close to that estimated by our study. Second----ours was a large community-based study as compared to other studies which are hospital-/ laboratorybased and checked the population at their doorstep and included the population across all the spectrum of age and sex so that we think it truly reflects the load of disease at least in the Southern Punjab. 
